ABSTRACT
The Babraham pig is a highly inbred breed first developed in the United Kingdom approximately 50 years ago. Previous reports indicate a very high degree of homozygosity across the genome, including the major histocompatibility complex (MHC) region, but confirmation of homozygosity at the specific MHC loci was lacking. Using both direct sequencing and PCR-based sequence-specific typing, we confirm that Babraham pigs are essentially homozygous at their MHC loci and formalise their MHC haplotype as Hp-55.6. This enhances the utility of the Babraham pig as a useful biomedical model for studies in which controlling for genetic variation is important.
ABSTRACT
The lung is the portal of entry for Mycobacterium tuberculosis (Mtb) and animal experimental evidence indicates that local immune defense mechanisms are crucial for protective immunity. Immunization via the lower respiratory tract efficiently induces a dividing, activated, antigen-dependent, lung-resident, memory T-cell population, which is partly recoverable by bronchoalveolar lavage. These cells can inhibit the growth of Mtb in the lungs immediately after infection. Delivery of appropriate signals to the lung innate immune system is critical for induction of effective local immunity. In contrast after parenteral immunization, antigen-specific cells may be found in lung tissue but few are recoverable by lavage and inhibition of mycobacterial growth is delayed. Harnessing both local and systemic immunity can provide highly effective protection in animal models and the evidence suggests that taken in aggregate, multiple animal models may predict the success of novel vaccine strategies in humans.
Subject(s)
Mycobacterium tuberculosis/immunology , Tuberculosis Vaccines/immunology , Tuberculosis/immunology , Tuberculosis/prevention & control , Animals , BCG Vaccine/immunology , Humans , Immunity, InnateABSTRACT
The distribution of carcinoembryonic antigen (CEA) in colorectal cancer (CRC) differs from that in normal colorectal tissue, being found on all borders of the cell membrane and hence enabling access to intravenous antibody, making CEA a good target for antibody-based therapy. The distinctive anti-CEA antibody, PR1A3, binds only membrane-bound CEA. Humanised PR1A3 (hPR1A3) was assessed both in vitro cytotoxicity and binding assays with colorectal cancer cell lines expressing varying levels of CEA. Human peripheral blood mononuclear cells (PBMCs) and purified natural killer (NK) cells were used as effectors. The in vitro assays demonstrated hPR1A3 CEA-specific binding and antibody-dependent and CEA-specific killing of human colorectal cancer cell lines by human PBMCs. The effect increased with increasing concentration of antibody and surface CEA, and was lost by using the parent murine IgG1 PR1A3. Killing was also blocked by antibody to the Fc-gammaIIIA receptor. Purified human NK cells were effective at much lower effector:target ratios than unfractionated PBMCs, indicating that NK cells were the main mediators of hPR1A3-based CEA-specific killing. The results support the development of hPR1A3 for therapy of colorectal cancer.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Carcinoembryonic Antigen/metabolism , Colorectal Neoplasms/therapy , Antibodies, Monoclonal, Murine-Derived , Antibodies, Neoplasm/pharmacology , Antibody Specificity , Antigen-Antibody Complex/metabolism , Antigens, Neoplasm/metabolism , Antigens, Surface/metabolism , Carcinoembryonic Antigen/immunology , Cell Line, Tumor , Cytotoxicity, Immunologic , Drug Delivery Systems , Humans , Immunoglobulin Fab Fragments/immunology , Immunoglobulin G/therapeutic use , Killer Cells, Natural/immunology , Receptors, IgG/immunologyABSTRACT
CD45 is a haemopoietic tyrosine phosphatase, crucial for lymphocyte signalling. Two polymorphisms (C77G and A138G), which alter CD45 isoform expression, are associated with autoimmune and infectious diseases. Using HapMap data, we show that there is substantial linkage disequilibrium across the CD45 gene (PTPRC), with similar patterns in different populations. Employing a set of single nucleotide polymorphisms, correlated with a substantial proportion of variation across this gene, we tested for association with type 1 diabetes, Graves' disease in a Japanese population, hepatitis C in UK population and tuberculin response in a Chinese population. A limited number of common haplotypes was found. Most 138G alleles are present on only one haplotype, which is associated with Graves' disease, supporting previous data that A138G is a functionally important CD45 polymorphism.
Subject(s)
Diabetes Mellitus, Type 1/genetics , Genetic Predisposition to Disease , Graves Disease/genetics , Leukocyte Common Antigens/genetics , Polymorphism, Single Nucleotide , Alleles , Ascariasis/genetics , Ascariasis/parasitology , China , Haplotypes , Hepatitis C/genetics , Humans , Japan , Parasite Egg Count , Tuberculin/immunology , United KingdomABSTRACT
Quantitation of bacterial load in tissues is essential for experimental investigation of Mycobacterium tuberculosis infection and immunity. We have used an automated liquid culture system to determine the number of colony forming units (CFU) in murine tissues and compared the results to those obtained by conventional plating on Middlebrook agar. There is an overall good correlation between results obtained by the two methods. Although less consistency and more contamination was observed in the automated liquid culture, the method is more sensitive, less labour intensive and allows the processing of large numbers of samples.
Subject(s)
Culture Media , Disease Models, Animal , Lung/microbiology , Mycobacterium tuberculosis/isolation & purification , Spleen/microbiology , Tuberculosis, Pulmonary/microbiology , Agar , Animals , Bacteriological Techniques , Colony Count, Microbial , Female , Humans , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Sensitivity and SpecificityABSTRACT
CD45, the leucocyte common antigen, is a haematopoietic cell specific tyrosine phosphatase. Human polymorphic CD45 variants are associated with autoimmune and infectious diseases and alter the phenotype and function of lymphocytes, establishing CD45 as an important regulator of immune function. Here we report four patients with diverse diseases with unusual clinical features. All four have the C77G polymorphism of CD45 exon 4, which alters the splicing and CD45RA/CD45R0 phenotype of lymphocytes. We suggest that C77G may be a contributing factor in these unusual cases.
Subject(s)
Common Variable Immunodeficiency/genetics , Leukocyte Common Antigens/genetics , Opportunistic Infections/genetics , Polymorphism, Genetic , Abscess/genetics , Abscess/immunology , Adult , Child , Common Variable Immunodeficiency/immunology , Female , Genetic Predisposition to Disease , Humans , Immunocompromised Host/genetics , Male , Middle Aged , Myocarditis/genetics , Myocarditis/immunology , Opportunistic Infections/immunology , RNA Splicing , Salmonella Infections/genetics , Salmonella Infections/immunology , Splenic Diseases/genetics , Splenic Diseases/immunologyABSTRACT
BACKGROUND: A polymorphism in exon 4 (C77G) of CD45 that alters CD45 splicing has been associated with autoimmune and infectious diseases in humans. OBJECTIVE: To investigate the effect of C77G in hepatitis C virus (HCV) infected individuals and study the phenotype and function of peripheral blood mononuclear cells (PBMC) from healthy and hepatitis C infected C77G carriers. RESULTS: C77G individuals showed an increased proportion of primed CD45RA and effector memory CD8 T cells and more rapid activation of the lymphocyte specific protein tyrosine kinase (Lck) following CD3 stimulation. Transgenic mice with CD45 expression mimicking that in human C77G variants had more activated/memory T cells, more rapid proliferative responses, and activation of Lck. CONCLUSIONS: Changes in CD45 isoform expression can alter immune function in human C77G variants and CD45 transgenic mice. The C77G allele may influence the outcome of HCV infection.
Subject(s)
Carrier State/immunology , Hepatitis C/genetics , Hepatitis C/immunology , Leukocyte Common Antigens/genetics , Leukocyte Common Antigens/metabolism , Animals , Biomarkers , Cell Proliferation , Exons/genetics , Female , Flow Cytometry , Gene Expression , Humans , Lymphocyte Activation/immunology , Male , Mice , Mice, Transgenic , Phenotype , Polymorphism, Single Nucleotide/genetics , Signal Transduction , T-Lymphocytes/cytology , T-Lymphocytes/immunologyABSTRACT
The CD45 antigen is essential for normal antigen receptor-mediated signalling in lymphocytes, and different patterns of splicing of CD45 are associated with distinct functions in lymphocytes. Here we show that abnormal CD45 splicing caused by a C77G transversion in exon A of the gene encoding CD45 (PTPRC) is associated with increased susceptibility to HIV-1 infection.
Subject(s)
Genetic Predisposition to Disease , HIV Infections/genetics , HIV-1 , Leukocyte Common Antigens/genetics , Point Mutation , Alternative Splicing , Exons/genetics , HIV Infections/immunology , Humans , Leukocyte Common Antigens/metabolism , Leukocytes, Mononuclear/immunologyABSTRACT
A 77G allele of the gene encoding CD45, also known as the protein tyrosine phosphatase receptor-type C gene (PTPRC), has been associated with multiple sclerosis (MS). Here we determine allele frequencies in large numbers of MS patients, primary immunodeficiencies linked to major histocompatibility complex (MHC) locus and over 1,000 controls to assess whether aberrant splicing of PTPRC caused by the 77C-->G polymorphism results in increased susceptibility to these diseases. Our results show no difference in the frequency of the 77G allele in patients and controls and thus do not support a causative role for the polymorphism in the development of disorders with a strong autoimmune component in etiology.
Subject(s)
Autoimmune Diseases/genetics , Leukocyte Common Antigens/genetics , Major Histocompatibility Complex/genetics , Point Mutation , Animals , Chromosomes, Human, Pair 1 , Genotype , Humans , RNA SplicingABSTRACT
The leukocyte common (CD45) Ag is essential for normal T lymphocyte function and alternative splicing at the N terminus of the gene is associated with changes in T cell maturation and differentiation. Recently, a statistically significant association was reported in a large series of human thymus samples between phenotypically abnormal CD45 splicing and the presence of the CC chemokine receptor 5 deletion 32 (CCR5del32) allele, which confers resistance to HIV infection in homozygotes. We show here that abnormal splicing in these thymus samples is associated with the presence of the only established cause of CD45 abnormal splicing, a C77G transversion in exon A. In addition we have examined 227 DNA samples from peripheral blood of healthy donors and find no association between the exon A (C77G) and CCR5del32 mutations. Among 135 PBMC samples, tested by flow cytometric analysis, all those exhibiting abnormal splicing of CD45 also showed the exon A C77G transversion. We conclude that the exon A (C77G) mutation is a common cause of abnormal CD45 splicing and that further disease association studies of this mutation are warranted.
Subject(s)
Alternative Splicing/immunology , Exons/genetics , Exons/immunology , Leukocyte Common Antigens/genetics , Point Mutation , Alternative Splicing/genetics , Child , Cytosine , Flow Cytometry , Genetic Linkage/immunology , Guanine , Humans , Leukocyte Common Antigens/blood , Leukocytes, Mononuclear/enzymology , Leukocytes, Mononuclear/immunology , Protein Tyrosine Phosphatases/blood , Protein Tyrosine Phosphatases/genetics , Receptors, CCR5/blood , Receptors, CCR5/genetics , Sequence Deletion/immunology , Thymus Gland/enzymology , Thymus Gland/immunologyABSTRACT
SCID is a heterogeneous group of hereditary diseases. Mutations in the common gamma-chain (gamma(c)) of cytokine receptors, including those for IL-2, IL-4, IL-7, IL-9, and IL-15, are responsible for an X-linked form of the disease, while mutations of several other genes, including Janus-associated kinase-3, may cause autosomal recessive forms of SCID. We investigated the first SCID patient to be described with minimal cell surface expression of the leukocyte common (CD45) Ag. CD45 is an abundant transmembrane tyrosine phosphatase, expressed on all leukocytes, and is required for efficient lymphocyte signaling. CD45-deficient mice are severely immunodeficient and have very few peripheral T lymphocytes. We report here that a homozygous 6-bp deletion in the gene encoding CD45 (PTPRC, gene map locus 1q31-32), which results in a loss of glutamic acid 339 and tyrosine 340 in the first fibronectin type III module of the extracellular domain of CD45, is associated with failure of surface expression of CD45 and SCID. Molecular modeling suggests that tyrosine 340 is crucial for the structural integrity of CD45 protein. This is the second description of a clinically relevant CD45 mutation, provides direct evidence for the importance of CD45 in immune function in humans, and suggests that abnormalities in CD45 expression are a possible cause of SCID in humans.
Subject(s)
Leukocyte Common Antigens/genetics , Sequence Deletion/immunology , Severe Combined Immunodeficiency/genetics , Severe Combined Immunodeficiency/immunology , Amino Acid Sequence , Animals , Base Sequence , CHO Cells , Cell Line , Cell Membrane/genetics , Cell Membrane/immunology , Cell Membrane/metabolism , Cricetinae , Female , Fibronectins/genetics , Glutamic Acid/genetics , Humans , Infant , Leukocyte Common Antigens/biosynthesis , Leukocyte Common Antigens/chemistry , Mice , Molecular Sequence Data , Polymorphism, Genetic , Protein Structure, Tertiary/genetics , Severe Combined Immunodeficiency/diagnosis , Severe Combined Immunodeficiency/ethnology , Transfection , Tumor Cells, Cultured , Tyrosine/chemistry , Tyrosine/geneticsABSTRACT
We have investigated the role of specific components of the thymic stroma during development of CD4-8-T cell precursors by separating and reaggregating precursor subsets with individual or combinations of stromal cells. We show that while the development of CD25+ 44+ precursors is dependent upon a combination of major histocompatibility complex (MHC) class II+ thymic epithelial cells and fibroblasts, their direct descendants, CD25+ 44- precursors, develop to the CD4+ 8+ stage in the presence of MHC class II+ thymic epithelial cells alone. Thus, CD25+ 44+ precursors are the last developmental stage to be dependent upon fibroblast support. In addition, while metabolically inactive, 1-ethyl-3-(3'-dimethylaminopropyl) carbodiimide (ECDI)-treated fibroblasts retain the ability to promote T cell development, prior treatment with hyaluronidase abrogates this effect, suggesting that fibroblast-associated extracellular matrix components are the key elements involved. In support of this, we show that fibroblasts are located in cortical regions of the thymus where T cell precursors are known to reside, and that these fibroblasts are associated with an extensive extracellular matrix not found on thymic epithelial cells. Finally, antibodies to alpha 4 integrin and CD44 interfere with the efficiency with which CD4+ 8+ cells are generated from CD25+ 44+ precursors in reaggregate cultures and also reduce the binding of the latter to 3T3 fibroblasts, suggesting these molecules play a role in bringing T cell precursors into contact with fibroblast-associated extracellular matrix.
Subject(s)
Cell Communication/immunology , Extracellular Matrix Proteins/metabolism , Hyaluronan Receptors/analysis , Receptors, Interleukin-2/analysis , T-Lymphocyte Subsets/cytology , Thymus Gland/cytology , 3T3 Cells , Animals , Animals, Newborn , Antibodies, Monoclonal/immunology , Antigens, CD/immunology , CD4 Antigens/analysis , CD8 Antigens/analysis , Cell Aggregation/immunology , Cell Differentiation/immunology , Ethyldimethylaminopropyl Carbodiimide , Extracellular Matrix Proteins/biosynthesis , Fibroblasts/immunology , Hematopoietic Stem Cells/immunology , Hyaluronan Receptors/immunology , Hyaluronoglucosaminidase , Integrin alpha4 , Mice , Mice, Inbred BALB C , Rabbits , Stromal Cells/immunology , T-Lymphocyte Subsets/immunology , Thymus Gland/embryology , Thymus Gland/growth & developmentABSTRACT
We have shown that an antibody (9C10) to the alpha 4 integrin induces apoptosis in murine immature CD4+ CD8+ thymocytes and in activated (but not resting) mature lymph node T cells. In both cases, apoptosis is blocked by the highly selective protein kinase C (PKC) inhibitor Ro31.8425, suggesting that 9C10 induces signalling through the alpha 4 integrin resulting in PKC activation leading to apoptosis. Overall, our results indicate the potential role of the alpha 4 integrin-mediated interactions in apoptosis induction during T-cell development and following mature T-cell activation.
Subject(s)
Antigens, CD/immunology , Apoptosis/immunology , Enterotoxins/immunology , Superantigens/immunology , T-Lymphocyte Subsets/immunology , Animals , Apoptosis/drug effects , Female , Indoles/pharmacology , Integrin alpha4 , Lymph Nodes/immunology , Lymphocyte Activation/immunology , Maleimides/pharmacology , Mice , Mice, Inbred BALB C , Protein Kinase C/antagonists & inhibitors , Staphylococcus aureus/immunology , Thymus Gland/immunologyABSTRACT
Ligation of T-cell receptor (TCR) causes mature T cells to proliferate or, on re-exposure to antigen, can cause them to die by activation-induced cell death (AICD). In proliferative responses, costimulatory and adhesive interactions are required and activation of protein kinase C (PKC) has been shown to be essential. Whether or not interactions involving costimulatory signals and PKC have a role in facilitating AICD remains unclear. Here we have examined the role of CD28/B7 and leucocyte function associated antigen-1 (LFA-1)/intracellular adhesion molecule (ICAM) mediated interactions in AICD triggered by staphylococcal enterotoxin B (SEB) in murine lymph node T cells. We show that, after a primary proliferative response to SEB, LFA-1/ICAM-2 adhesive interactions can play a part in AICD following SEB rechallenge, while B7 and ICAM-1 mediated interactions are not essential for this process. In addition, using a highly selective PKC inhibitor, Ro31.8425, we show that PKC activation is essential for the regulation of AICD by SEB rechallenge.
Subject(s)
Antigens, CD/immunology , Apoptosis/immunology , Cell Adhesion Molecules/immunology , Enterotoxins/immunology , Lymphocyte Function-Associated Antigen-1/immunology , Protein Kinase C/immunology , Animals , Antigen-Presenting Cells/immunology , B7-1 Antigen/analysis , Cell Culture Techniques , Female , Guinea Pigs , Histocompatibility Antigens Class II/analysis , Lymph Nodes/immunology , Lymphocyte Activation , Mice , Mice, Inbred BALB C , T-Lymphocytes/immunologyABSTRACT
CD33 monoclonal antibodies recognize a 67-kD glycoprotein of unknown function that is expressed by early myeloid progenitors and their leukemic counterparts. We report here the cloning of the murine homolog of the human CD33 antigen. Two cDNA clones, differing by an 83-nucleotide insertion in the cytoplasmic region, were isolated. The insertion generated a shift in the reading frame within the cytoplasmic tail, resulting in two mouse CD33 isoforms, m33-A and m33-B, with distinct cytoplasmic domains and with predicted protein core molecular weights of 37 kD and 45 kD, respectively. The cDNAs and deduced amino acid sequences show extensive similarity with the human CD33 sequence with the highest homology occurring in the first and second lg-like domains (61% amino acid identity). The most significant divergence between the human and murine proteins occurs in their cytoplasmic portions. The murine CD33 mRNAs were detected in bone marrow, spleen, thymus, brain, liver, the multipotential progenitor cell line, A4, the myelomonocytic cell line, WEHI3B, the myeloid cell line, M1, and the macrophage cell line, P388, by Northern blot analysis. The expression pattern of the murine CD33 homolog suggests that the function of CD33 antigen in hematopoiesis may be conserved between humans and mice.
Subject(s)
Antigens, CD/genetics , Antigens, Differentiation, Myelomonocytic/genetics , Amino Acid Sequence , Animals , Antigens, CD/chemistry , Antigens, Differentiation, Myelomonocytic/chemistry , Base Sequence , Cloning, Molecular , DNA, Complementary/isolation & purification , Humans , Mice , Molecular Sequence Data , Polymerase Chain Reaction , RNA Splicing , Sequence Homology, Amino Acid , Sialic Acid Binding Ig-like Lectin 3ABSTRACT
Preliminary results from the IVth Leucocyte Culture Conference have classified the monoclonal antibody (MoAb), YTH 71.3.2, as CD66. Two other MoAbs, YPC 2/12.1 and CE6/2D3.1, share a common cellular specificity, reacting with cells of the neutrophil series and colonic epithelium. The YTH 71.3.2 and CE6/2D3.1 MoAbs both recognize a similar CD66 defined epitope that is distinct from that identified by YPC 2/12.1. By Western blotting, these antibodies react with different molecular species from cells of different lineages. The antibodies identify 50- to 55-Kd, 80- to 100-Kd, and 130- to 200-Kd components present in a semi-purified carcinoembryonic antigen (CEA) preparation from colonic adenocarcinomas and a 90- to 130-Kd molecule from HL-60 cells. With the colonic cell line, LS174T, YPC2/12.1 stains diffuse bands of 160 to 200 Kd and 90 to 130 Kd with equal intensity, whereas the binding of CE6/2D3.1 and YTH 71.3.2 is biased toward the lower molecular weight set of molecules. Remarkably, all three antibodies recognize CEA-related molecules. Defined analyses using HeLa cells transfected with CEA, NCA(NCA-50/90), and CGM6(NCA-95) cDNAs show that the three MoAbs identify CEA to varying degrees. While YTH 71.3.2 and CE6/2D3.1 also bind to NCA-50/90, YPC 2/12.1 recognizes an epitope expressed by both the NCA-50/90 and NCA-95 molecular species.
Subject(s)
Antigens, CD/analysis , Antigens, Differentiation/analysis , Carcinoembryonic Antigen/immunology , Cell Adhesion Molecules/immunology , Epitopes/immunology , Hematopoietic System/immunology , Neutrophils/immunology , Antibodies, Monoclonal/immunology , Antigens, CD/immunology , Antigens, Differentiation/immunology , Binding, Competitive , Blotting, Western , Bone Marrow/immunology , Bone Marrow Cells , Flow Cytometry , HeLa Cells , Humans , Leukocytes/cytology , Leukocytes/immunology , TransfectionABSTRACT
125I-insulin binding was studied in membrane preparations of olfactory bulb, frontal cortex, hippocampus and hypothalamus from mature (5-month-old) and aged (22-month-old) rats. In the young animals the highest level of specific insulin binding was found in the olfactory bulb, with lower values of specific insulin binding in the frontal cortex, hippocampus and hypothalamus. In the aged rats the specific insulin binding was not changed in the frontal cortex, hippocampus and hypothalamus as compared to the young ones. A significant decrease of total insulin binding was observed only in the olfactory bulbs of aged rats (0.67 +/- 0.04 pmol insulin/mg protein) as compared to the mature animals (1.3 +/- 0.08 pmol insulin/mg protein). Scatchard analysis of insulin binding data revealed that this decrease was due to changes in the number of binding sites rather than to changes in the affinity of insulin receptors. It was suggested that the decrease observed in insulin receptor number in olfactory bulbs of aged rats might be due to the atrophic changes in the structure of olfactory bulbs previously shown by electron microscopy for aged rats.